Mixed Results With Metformin for Men on ADT for Prostate Cancer



(MedPage Today) — Metformin failed to prevent metabolic syndrome in men on hormonal therapy for prostate cancer but did improve risk factors associated with the syndrome, an abbreviated randomized trial showed.
The proportion of patients with…



Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/118196

Author :

Publish date : 2025-10-28 21:34:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version